Human Anti-HLA-DRA Recombinant Antibody (clone ChDN1924)

This product is a recombinant chimeric (human/mouse) antibody that recognizes the first HLA-DR domains. Chimeric DN1924 is effective in inducing apoptosis in HLA-DR-expressing tumor cells, but not in HLA-DR-negative tumor cells or in normal HLA-DR-expressing cells. It has the potential to reduce the rate of tumor growth and promote increased survival.
Supplier Creative Biolabs
Product # HPAB-0025-YJ
Pricing Inquiry
Host Human
Target HLA-DRA
Species Reactivity Human
Type Chimeric (mouse/human) IgG2, κ
Applications Apop, IF
Storage Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback